PapersPMID:22166897
Effects of rose hip intake on risk markers of type 2 diabetes and cardiovascular disease: a randomized, double-blind, cross-over investigation in obese persons.
- findings
- 5
- compound
- 1
- endpoints
- 5
- no difference found
- 3
- Study, every finding
- crossover · 6 weeks
- Dose studied, every finding
- 5 dl rose hip drink per day for 6 weeks
What moved
How to read these marks →“Intake of the rose hip drink was found to result in a small but significant reduction in plasma levels of total cholesterol (−4.9% P=0.0018), as well as LDL cholesterol (−6.0% P=0.012), compared the intake of the control drink.”
- Population
- Obese adults (BMI > 30) without diabetes, some with impaired glucose tolerance, on an energy-restricted diet in both periods; eight on statins
- Decreases LDL cholesterol
limited
- Population
- Obese adults (BMI > 30) without diabetes, some with impaired glucose tolerance, on an energy-restricted diet in both periods; eight on statins
What did not
“Daily intake of the rose hip drink was found to have no effect on body weight and body mass index (Table 3).”
- Population
- Obese adults (BMI > 30) without diabetes, on an energy-restricted diet in both periods
- Population
- Obese adults (BMI > 30) without diabetes, on an energy-restricted diet in both periods
“Furthermore, no effects were observed on HbA1c or fasting levels of plasma glucose and insulin (Table 3), indicating that rose hip intake had no effects on glucose tolerance or insulin sensitivity.”
- Population
- Obese adults (BMI > 30) without diabetes, some with impaired glucose tolerance, on an energy-restricted diet in both periods
Study record
- Design
- crossover trial
- Species
- human
- Population
- Obese individuals (body mass index>30) with normal or impaired glucose tolerance, Lund University Hospital
- Participants
- 31
- Comparator
- placebo
- Duration
- 42 days
- Endpoints measured
- 24